早期陣痛治療の世界市場（～2026年）

• 英文タイトル：Global Preterm Labor Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04368
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は早期陣痛治療のグローバル市場について調査・分析したレポートです。種類別（子宮収縮抑制薬、ベータ–模倣薬、カルシウムチャネル遮断薬、NSAIDS、コルチコステロイド、硫酸マグネシウム、抗生物質）市場規模、用途別（病院、小児科および新生児クリニック、ナーシングホーム、薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別早期陣痛治療の競争状況、市場シェア
・世界の早期陣痛治療市場：種類別市場規模 2015年-2020年（子宮収縮抑制薬、ベータ–模倣薬、カルシウムチャネル遮断薬、NSAIDS、コルチコステロイド、硫酸マグネシウム、抗生物質）
・世界の早期陣痛治療市場：種類別市場規模予測 2021年-2026年（子宮収縮抑制薬、ベータ–模倣薬、カルシウムチャネル遮断薬、NSAIDS、コルチコステロイド、硫酸マグネシウム、抗生物質）
・世界の早期陣痛治療市場：用途別市場規模 2015年-2020年（病院、小児科および新生児クリニック、ナーシングホーム、薬局）
・世界の早期陣痛治療市場：用途別市場規模予測 2021年-2026年（病院、小児科および新生児クリニック、ナーシングホーム、薬局）
・北米の早期陣痛治療市場分析：米国、カナダ
・ヨーロッパの早期陣痛治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの早期陣痛治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の早期陣痛治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの早期陣痛治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Pfizer、Novartis、Merck、Sanofi、Johnson and Johnson、GSK、AstraZeneca、Cipla
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Preterm labor is defined as regular contractions of the uterus resulting in changes in the cervix that start before 37 weeks of pregnancy.
Increase in premature birth cases and rapid increase birthrate are major driving factors of preterm labor treatment market.

Market Analysis and Insights: Global Preterm Labor Treatment Market
The global Preterm Labor Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Preterm Labor Treatment Scope and Market Size
Preterm Labor Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Preterm Labor Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Novartis
Merck
Sanofi
Johnson and Johnson
GSK
AstraZeneca
Cipla

Market segment by Type, the product can be split into
Tocolytic Drugs
Beta – Mimetic
Calcium Channel Blockers
NSAIDS
Corticosteroids
Magnesium Sulphate
Antibiotics
Market segment by Application, split into
Hospitals
Pediatric and Neonatal Clinics
Nursing Homes
Pharmacy

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Preterm Labor Treatment Revenue
1.4 Market by Type
1.4.1 Global Preterm Labor Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Tocolytic Drugs
1.4.3 Beta – Mimetic
1.4.4 Calcium Channel Blockers
1.4.5 NSAIDS
1.4.6 Corticosteroids
1.4.7 Magnesium Sulphate
1.4.8 Antibiotics
1.5 Market by Application
1.5.1 Global Preterm Labor Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Pediatric and Neonatal Clinics
1.5.4 Nursing Homes
1.5.5 Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Preterm Labor Treatment Market Perspective (2015-2026)
2.2 Global Preterm Labor Treatment Growth Trends by Regions
2.2.1 Preterm Labor Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Preterm Labor Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Preterm Labor Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Preterm Labor Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Preterm Labor Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Preterm Labor Treatment Players by Market Size
3.1.1 Global Top Preterm Labor Treatment Players by Revenue (2015-2020)
3.1.2 Global Preterm Labor Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Preterm Labor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Preterm Labor Treatment Market Concentration Ratio
3.2.1 Global Preterm Labor Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Preterm Labor Treatment Revenue in 2019
3.3 Preterm Labor Treatment Key Players Head office and Area Served
3.4 Key Players Preterm Labor Treatment Product Solution and Service
3.5 Date of Enter into Preterm Labor Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Preterm Labor Treatment Historic Market Size by Type (2015-2020)
4.2 Global Preterm Labor Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Preterm Labor Treatment Market Size by Application (2015-2020)
5.2 Global Preterm Labor Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Preterm Labor Treatment Market Size (2015-2020)
6.2 Preterm Labor Treatment Key Players in North America (2019-2020)
6.3 North America Preterm Labor Treatment Market Size by Type (2015-2020)
6.4 North America Preterm Labor Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Preterm Labor Treatment Market Size (2015-2020)
7.2 Preterm Labor Treatment Key Players in Europe (2019-2020)
7.3 Europe Preterm Labor Treatment Market Size by Type (2015-2020)
7.4 Europe Preterm Labor Treatment Market Size by Application (2015-2020)

8 China
8.1 China Preterm Labor Treatment Market Size (2015-2020)
8.2 Preterm Labor Treatment Key Players in China (2019-2020)
8.3 China Preterm Labor Treatment Market Size by Type (2015-2020)
8.4 China Preterm Labor Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Preterm Labor Treatment Market Size (2015-2020)
9.2 Preterm Labor Treatment Key Players in Japan (2019-2020)
9.3 Japan Preterm Labor Treatment Market Size by Type (2015-2020)
9.4 Japan Preterm Labor Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Preterm Labor Treatment Market Size (2015-2020)
10.2 Preterm Labor Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Preterm Labor Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Preterm Labor Treatment Market Size by Application (2015-2020)

11 India
11.1 India Preterm Labor Treatment Market Size (2015-2020)
11.2 Preterm Labor Treatment Key Players in India (2019-2020)
11.3 India Preterm Labor Treatment Market Size by Type (2015-2020)
11.4 India Preterm Labor Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Preterm Labor Treatment Market Size (2015-2020)
12.2 Preterm Labor Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Preterm Labor Treatment Market Size by Type (2015-2020)
12.4 Central & South America Preterm Labor Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Preterm Labor Treatment Introduction
13.1.4 Pfizer Revenue in Preterm Labor Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Preterm Labor Treatment Introduction
13.2.4 Novartis Revenue in Preterm Labor Treatment Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Preterm Labor Treatment Introduction
13.3.4 Merck Revenue in Preterm Labor Treatment Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Sanofi
13.4.1 Sanofi Company Details
13.4.2 Sanofi Business Overview
13.4.3 Sanofi Preterm Labor Treatment Introduction
13.4.4 Sanofi Revenue in Preterm Labor Treatment Business (2015-2020)
13.4.5 Sanofi Recent Development
13.5 Johnson and Johnson
13.5.1 Johnson and Johnson Company Details
13.5.2 Johnson and Johnson Business Overview
13.5.3 Johnson and Johnson Preterm Labor Treatment Introduction
13.5.4 Johnson and Johnson Revenue in Preterm Labor Treatment Business (2015-2020)
13.5.5 Johnson and Johnson Recent Development
13.6 GSK
13.6.1 GSK Company Details
13.6.2 GSK Business Overview
13.6.3 GSK Preterm Labor Treatment Introduction
13.6.4 GSK Revenue in Preterm Labor Treatment Business (2015-2020)
13.6.5 GSK Recent Development
13.7 AstraZeneca
13.7.1 AstraZeneca Company Details
13.7.2 AstraZeneca Business Overview
13.7.3 AstraZeneca Preterm Labor Treatment Introduction
13.7.4 AstraZeneca Revenue in Preterm Labor Treatment Business (2015-2020)
13.7.5 AstraZeneca Recent Development
13.8 Cipla
13.8.1 Cipla Company Details
13.8.2 Cipla Business Overview
13.8.3 Cipla Preterm Labor Treatment Introduction
13.8.4 Cipla Revenue in Preterm Labor Treatment Business (2015-2020)
13.8.5 Cipla Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Preterm Labor Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Preterm Labor Treatment Revenue
Table 3. Ranking of Global Top Preterm Labor Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Preterm Labor Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tocolytic Drugs
Table 6. Key Players of Beta – Mimetic
Table 7. Key Players of Calcium Channel Blockers
Table 8. Key Players of NSAIDS
Table 9. Key Players of Corticosteroids
Table 10. Key Players of Magnesium Sulphate
Table 11. Key Players of Antibiotics
Table 12. Global Preterm Labor Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Preterm Labor Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Preterm Labor Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Preterm Labor Treatment Market Share by Regions (2015-2020)
Table 16. Global Preterm Labor Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Preterm Labor Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Preterm Labor Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Preterm Labor Treatment Players
Table 23. Global Preterm Labor Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Preterm Labor Treatment Market Share by Players (2015-2020)
Table 25. Global Top Preterm Labor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preterm Labor Treatment as of 2019)
Table 26. Global Preterm Labor Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Preterm Labor Treatment Product Solution and Service
Table 29. Date of Enter into Preterm Labor Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Preterm Labor Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Preterm Labor Treatment Market Size Share by Type (2015-2020)
Table 33. Global Preterm Labor Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Preterm Labor Treatment Market Size Share by Application (2015-2020)
Table 35. Global Preterm Labor Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Preterm Labor Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Preterm Labor Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Preterm Labor Treatment Market Share (2019-2020)
Table 39. North America Preterm Labor Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Preterm Labor Treatment Market Share by Type (2015-2020)
Table 41. North America Preterm Labor Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Preterm Labor Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Preterm Labor Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Preterm Labor Treatment Market Share (2019-2020)
Table 45. Europe Preterm Labor Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Preterm Labor Treatment Market Share by Type (2015-2020)
Table 47. Europe Preterm Labor Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Preterm Labor Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Preterm Labor Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Preterm Labor Treatment Market Share (2019-2020)
Table 51. China Preterm Labor Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Preterm Labor Treatment Market Share by Type (2015-2020)
Table 53. China Preterm Labor Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Preterm Labor Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Preterm Labor Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Preterm Labor Treatment Market Share (2019-2020)
Table 57. Japan Preterm Labor Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Preterm Labor Treatment Market Share by Type (2015-2020)
Table 59. Japan Preterm Labor Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Preterm Labor Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Preterm Labor Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Preterm Labor Treatment Market Share (2019-2020)
Table 63. Southeast Asia Preterm Labor Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Preterm Labor Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Preterm Labor Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Preterm Labor Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Preterm Labor Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Preterm Labor Treatment Market Share (2019-2020)
Table 69. India Preterm Labor Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Preterm Labor Treatment Market Share by Type (2015-2020)
Table 71. India Preterm Labor Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Preterm Labor Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Preterm Labor Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Preterm Labor Treatment Market Share (2019-2020)
Table 75. Central & South America Preterm Labor Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Preterm Labor Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Preterm Labor Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Preterm Labor Treatment Market Share by Application (2015-2020)
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Preterm Labor Treatment Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Preterm Labor Treatment Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Product
Table 92. Merck Revenue in Preterm Labor Treatment Business (2015-2020) (Million US$)
Table 93. Merck Recent Development
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Product
Table 97. Sanofi Revenue in Preterm Labor Treatment Business (2015-2020) (Million US$)
Table 98. Sanofi Recent Development
Table 99. Johnson and Johnson Company Details
Table 100. Johnson and Johnson Business Overview
Table 101. Johnson and Johnson Product
Table 102. Johnson and Johnson Revenue in Preterm Labor Treatment Business (2015-2020) (Million US$)
Table 103. Johnson and Johnson Recent Development
Table 104. GSK Company Details
Table 105. GSK Business Overview
Table 106. GSK Product
Table 107. GSK Revenue in Preterm Labor Treatment Business (2015-2020) (Million US$)
Table 108. GSK Recent Development
Table 109. AstraZeneca Company Details
Table 110. AstraZeneca Business Overview
Table 111. AstraZeneca Product
Table 112. AstraZeneca Revenue in Preterm Labor Treatment Business (2015-2020) (Million US$)
Table 113. AstraZeneca Recent Development
Table 114. Cipla Business Overview
Table 115. Cipla Product
Table 116. Cipla Company Details
Table 117. Cipla Revenue in Preterm Labor Treatment Business (2015-2020) (Million US$)
Table 118. Cipla Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preterm Labor Treatment Market Share by Type: 2020 VS 2026
Figure 2. Tocolytic Drugs Features
Figure 3. Beta – Mimetic Features
Figure 4. Calcium Channel Blockers Features
Figure 5. NSAIDS Features
Figure 6. Corticosteroids Features
Figure 7. Magnesium Sulphate Features
Figure 8. Antibiotics Features
Figure 9. Global Preterm Labor Treatment Market Share by Application: 2020 VS 2026
Figure 10. Hospitals Case Studies
Figure 11. Pediatric and Neonatal Clinics Case Studies
Figure 12. Nursing Homes Case Studies
Figure 13. Pharmacy Case Studies
Figure 14. Preterm Labor Treatment Report Years Considered
Figure 15. Global Preterm Labor Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Preterm Labor Treatment Market Share by Regions: 2020 VS 2026
Figure 17. Global Preterm Labor Treatment Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Preterm Labor Treatment Market Share by Players in 2019
Figure 20. Global Top Preterm Labor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preterm Labor Treatment as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Preterm Labor Treatment Revenue in 2019
Figure 22. North America Preterm Labor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Preterm Labor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Preterm Labor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Preterm Labor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Preterm Labor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Preterm Labor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Preterm Labor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed

以下、関連資料のご紹介

早産治療の世界市場（～2026年）

Global Premature Labor Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04356 2020年11月20日 90Pages
当調査資料は早産治療のグローバル市場について調査・分析したレポートです。種類別（プロゲステロン、OBE-022、レトシバン、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド...

早産管理の世界市場（～2026年）

Global Preterm Birth Control Market Size, Status and Forecast 2020-2026
MRC2-11QY04367 2020年11月20日 94Pages
当調査資料は早産管理のグローバル市場について調査・分析したレポートです。種類別（デバイス、薬物治療）市場規模、用途別（病院、不妊治療クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台...

クラッベ病治療の世界市場（～2026年）

Global Krabbe Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12467 2020年11月25日 94Pages
当調査資料はクラッベ病治療のグローバル市場について調査・分析したレポートです。種類別（抗けいれん薬、筋弛緩薬、造血幹細胞移植、その他）市場規模、用途別（病院、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

アレルギー性鼻炎治療の世界市場（～2026年）

Global Allergic Rhinitis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY13652 2020年11月30日 91Pages
当調査資料はアレルギー性鼻炎治療のグローバル市場について調査・分析したレポートです。種類別（抗ヒスタミン薬、鼻腔内コルチコステロイド、免疫療法、充血除去薬、その他）市場規模、用途別（季節性アレルギー性鼻炎、通年性アレルギー性鼻炎）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イ...

変形性関節症治療の世界市場（～2026年）

Global Osteoarthritis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04111 2020年11月20日 98Pages
当調査資料は変形性関節症治療のグローバル市場について調査・分析したレポートです。種類別（薬物、支援機器）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリ...

結節性痒疹治療の世界市場（～2026年）

Global Prurigo Nodularis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04403 2020年11月20日 97Pages
当調査資料は結節性痒疹治療のグローバル市場について調査・分析したレポートです。種類別（カプサイシンクリーム、抗ヒスタミン薬、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

乳糖不耐症治療の世界市場（～2026年）

Global Lactose Intolerance Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12475 2020年11月25日 90Pages
当調査資料は乳糖不耐症治療のグローバル市場について調査・分析したレポートです。種類別（栄養補助食品、酵素ラクターゼサプリメント、その他）市場規模、用途別（病院・クリニック、在宅医療、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...

多発性骨髄腫治療の世界市場（～2026年）

Global Multiple Myeloma Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY03865 2020年11月20日 92Pages
当調査資料は多発性骨髄腫治療のグローバル市場について調査・分析したレポートです。種類別（プロテアソーム阻害剤、免疫調節剤（IMiD）、ヒストンデアセチラーゼ（HDAC）阻害剤、免疫療法、細胞毒性化学療法）市場規模、用途別（病院、診療所、がん治療・リハビリテーションセンター）市場規模、地域別（北米、米...

化膿性汗腺炎治療の世界市場（～2026年）

Global Hidradenitis Suppurativa Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12181 2020年11月25日 91Pages
当調査資料は化膿性汗腺炎治療のグローバル市場について調査・分析したレポートです。種類別（医薬品、手術、その他）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、...

尿路感染症治療の世界市場（～2026年）

Global Urinary Tract Infection Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04952 2020年11月20日 99Pages
当調査資料は尿路感染症治療のグローバル市場について調査・分析したレポートです。種類別（複雑なUTI、再発性の複雑なUTI、単純なUTI、神経因性膀胱感染症、その他）市場規模、用途別（病院薬局、婦人科および泌尿器科クリニック、ドラッグストア、小売薬局、オンラインドラッグストア）市場規模、地域別（北米、...

早産治療の世界市場（～2026年） Market Analysis and Insights: Global Premature Labor Treatment Market The global Premature Labor Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Premature Labor Treatment Scope and Market Size Premature Labor…
早産管理の世界市場（～2026年） Preterm birth is defined as babies born alive before 37 weeks of pregnancy completion. According to the World Health Organization (WHO), approximately 15 million babies that are victims of preterm birth every years. The identification of women with high risk of preterm birth is a major challenge til…
白血病治療薬の世界市場（～2026年） Leukemia Treatment Drugs is used to cure Leukemia. Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the leukemia therapeutics market. Market Analysis and Insights: Global Leukemia Treatment Drugs Market The glob…
バーター症候群治療の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. The global market for Bartter syndrome treatment is expected to witness a moderate growth rate over the forecast period. Market Analysis and Insights: Global Bartter Syndrome Treatment Market The global Bart…
ドライアイ治療薬・装置治療の世界市場（～2026年） Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry e…